![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/464542-504048140-final-veruinclogo-rgb-300dpi-jpg-100x71.jpeg)
Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
MIAMI, FL, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute …